Latest News

digestive tract | Image credit: sdecoret -
What Clinicians Need to Know About Using Biosimilars to Treat IBD

April 13th 2024

A review article, intended to act as a guide for clinicians, summarizes the available infliximab and adalimumab biosimilars for treating inflammatory bowel disease (IBD) as well as others that are coming down the pipeline.

syringe and doctor | Image credit: New Africa -
Biosimilars Council: PBM Rebate Schemes Cost Americans, Payers $6 Billion

April 10th 2024

biosimilars check-in banner
Biosimilar Business Recap: BI Layoffs; Teva, mAbxience Partnership; Phase 3 Keytruda Biosimilar Trial

April 8th 2024

data | Image credit: apinan -
Meta-Analysis Confirms Similar Safety, Efficacy Between Adalimumab Biosimilars, Humira

April 6th 2024

injectable pen | Image credit: Orawan -
The Totality of Evidence Supporting Adalimumab Biosimilar AVT02

March 30th 2024

© 2024 MJH Life Sciences

All rights reserved.